Navigating Executive Orders and DOJ Memos That Threaten Criminal Prosecution
FDA Law
MAY 26, 2025
Even if otherwise truthful, the promotion of off-label uses of hormones-including through informal campaigns like those conducted by sales reps or under the guise of sponsored continuing medical education courses-run afoul of the FDAs prohibitions on misbranding and mislabeling. First, it direct[s] all U.S. MedImmune, Inc. Genentech, Inc.,
59 
Let's personalize your content